Keyword: Bind Therapeutics


Bind and Pfizer in Tumor License Deal

28.09.2015 - US pharmaceutical giant Pfizer has exercised its option under the companies’ global collaboration agreement to take an exclusive license from Bind Therapeutics for the purpose of...


Big Drugmakers Think Small with Nanomedicine Deals

03.05.2013 - Is nanomedicine the next big thing? A growing number of top drug companies seem to think so. The ability to encapsulate potent drugs in tiny particles measuring billionths of a...


AstraZeneca Bets on Nanotech with Bind Therapeutics Deal

22.04.2013 - AstraZeneca is to pay privately held Bind Therapeutics as much as $200 million to develop a cancer medicine using the U.S. biotech company's nanotechnology drug delivery system...